| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 28,001 | 27,213 | 26,923 | 39,107 | | Cost of Revenue | 12,334 | 14,449 | 12,621 | 18,838 | | | Gross Profit | 15,667 | 12,764 | 14,302 | 20,269 | | | Operating Expenses | | Research Development | 6,119 | 6,054 | 8,185 | 8,809 | | Selling General and Administrative | 8,903 | 10,217 | 11,352 | 12,839 | | Non Recurring |
-
|
-
|
-
| 105,771 | | Others | 605 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 645 | (3,507) | (5,235) | (107,150) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 243 | 523 | 8,831 | 59 | | Earnings Before Interest And Taxes | 283 | (2,984) | 3,596 | (107,091) | | Interest Expense | 788 | 804 | 925 | 942 | | Income Before Tax | (505) | (3,788) | 2,671 | (108,033) | | Income Tax Expense | (23) | (391) | 663 | (1,237) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (118) | (3,397) | 2,008 | (106,796) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (482) | (3,397) | 2,008 | (106,796) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($482) | ($3,397) | $2,008 | ($106,796) |
|
0.02% Nasdaq 0.00%
Income Statement
